BioAtla, Inc. (BCAB)
0.7601
-0.01
(-1.76%)
USD |
NASDAQ |
Dec 11, 15:19
BioAtla EPS Diluted (Quarterly): -0.2686 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Context Therapeutics, Inc. | -0.1018 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.78M |
| Total Expenses (Quarterly) | 15.78M |
| Enterprise Value | 43.35M |
| Earnings Yield | -151.2% |
| Normalized Earnings Yield | -151.91 |